Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
OIG Addresses Status of PAMA Implementation
From - Laboratory Industry Report
Changes to Medicare Part B payment for lab tests mandated by the Protecting Access to Medicare Act of 2014 (PAMA) take effect on…
OIG Celebrates 40 Years of Fraud Fighting
From - National Intelligence Report
Oct. 15, 2016 marks 40 years since the U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) was launched in…
Patients Prefer Web Access to Test Results
From - Diagnostic Testing & Emerging Technologies
Patients increasingly prefer to receive laboratory test results via password-protected websites and portals, according to…
Remember to Check Excluded Status
From - G2 Compliance Advisor
Background checks aren't just for spotting criminal records. Are you checking the Office of Inspector General's List of…
Theranos Closes Labs to Focus on Technology Instead
From - Diagnostic Testing & Emerging Technologies
Despite appealing the Centers for Medicare and Medicaid's (CMS) sanctions resulting from inspection of…
DEA’s Takeback Initiative Coincides with Quest Survey Highlighting Misuse of Prescription Drugs
From - Laboratory Industry Report
The U.S. Drug Enforcement Administration's latest National Take-Back Initiative happens this month on Oct. 22, when the public is…
Don’t Overlook Bloodborne Pathogen Safety Issues
From - G2 Compliance Advisor
Violations of Medicare-related laws such as the Anti-Kickback Statute, self-referral law and the False Claims Act can cost…
Pay Equity Law Affects What You Can Ask Job Applicants
From - National Intelligence Report
Massachusetts recently signed into law An Act to Establish Pay Equity, S.2119, which takes effect on…
Clinical Single Cell Analysis Shows Promise
From - Diagnostic Testing & Emerging Technologies
Personalized medicine is driving the need for isolation of rarer target cell populations, including for the enrichment of…
Publicly-Traded Esoteric Labs Are Off to Good Start in 2016
From - Laboratory Industry Report
As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to…